01.02.2018 • News

Sipchem Mulls US Shale-based Projects

Saudi International Petrochemical Company (Sipchem) is considering investing in...
Saudi International Petrochemical Company (Sipchem) is considering investing in shale-based projects in the US (c) ZUMA Press Inc / Alamy Stock Photo

Saudi International Petrochemical Company (Sipchem) is considering investing in shale-based projects in the US, CEO Amad Al Ohali said in an interview with Bloomberg news agency.

An investment would represent the Saudi company’s first foreign venture and Al Ohali said it would likely need to partner with a US company.

In Saudi Arabia, growth prospects are unfortunately very limited due to a lack of feedstock for basic products, Al Ohali said. He told Bloomberg: “Our really big potential is more into the basic [products] in the US based on shale gas and we are looking into this area. It’s not going to be easy because we don’t know the business landscape in the US, but definitely we are targeting hopefully to do something this year.” He added that Sipchem would initially use cash to pay for the project instead of borrowing money.

Al Ohali also referred to the Saudi government’s increase in feedstock prices two years ago, describing it as a “wakeup call for our industry”.

Sipchem has been undertaking a restructuring program across its key functions as it strives to enhance its competitiveness and transform into a fully integrated petrochemical company. Ohali said this process will continue to create value in some areas, particularly marketing and research.

The company produces methanol, butanediol, tetrahydrofuran and other specialty chemicals, along with key intermediates such as acetic acid/anhydride and vinyl acetate monomer as well as polymers including LDPE and polybutylene terephthalate.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.